(Q48279514)

10 February 2018

title

Differential effects of first antiepileptic drug application on cognition in lesional and non-lesional patients with epilepsy (English)

1 reference

10 February 2018

author name string

C Helmstaedter

series ordinal

1

1 reference

10 February 2018

G Wagner

series ordinal

2

1 reference

10 February 2018

C E Elger

series ordinal

3

1 reference

10 February 2018

publication date

1 June 1993

1 reference

10 February 2018

Seizure-European Journal of Epilepsy

published in

1 reference

10 February 2018

volume

2

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

125-130

1 reference

10 February 2018

Improvement in cognitive functioning and mood state after conversion to valproate monotherapy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Psychotropic effects of carbamazepine in epilepsy: A double-blind comparison with phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Cognitive and motor-sensory performances in toxic and nontoxic epileptic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Serum phenytoin concentration and clinical response in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Anticonvulsant drugs and cognitive functions.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Comparative cognitive effects of anticonvulsants

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Carbamazepine versus phenobarbital for partial onset seizures in children

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Carbamazepine plasma concentration. Relationship to cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Valproate Sodium: Evaluation of So-called Psychotropic Effect. A Controlled Study

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Sodium valproate and cognitive functioning in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Neuropsychological effects of carbamazepine and phenytoin: a reanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Behavioral toxicity associated with antiepileptic drugs: concepts and methods of assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Diphenylhydantoin Serum Levels, Toxicity, and Neuropsychological Performance in Patients with Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

Motor speed is a contaminating factor in evaluating the "cognitive" effects of phenytoin.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980115-3

7 January 2021

10.1016/S1059-1311(05)80115-3

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018